Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04171661 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

Study acronym: SASS
StatusActive, Not Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv7
  2. Study completion date: Dec 10, 2024 to Dec 18, 2026v6
  3. Re-verified, no change to tracked fieldsv5
  4. Interventions: SASS (Other) to SASS (Biological)v4
  5. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    • Study title shortened, about 1 word
    v3
  6. Secondary endpoints revised (6)v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Single patient study. Patient diagnosed with dystrophic epidermolysis bullosa presenting chronic open wounds that are not responding to dressings, topical preparations (antimicrobials, antibiotics) and systemic agents (anti-inflammatory antibacterials). The Self-Assembled Skin Substitutes will be used to cover wounds.
Trial Details
NCT Number NCT04171661
Lead Sponsor CHU de Quebec-Universite Laval
Collaborators: The Hospital for Sick Children
Conditions
(from sponsor)		 Epidermolysis Bullosa Dystrophica
Related terms Epidermolysis Bullosa Dystrophica
Enrollment 1 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov